Cargando…

SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin

Cisplatin resistance has been a major factor limiting its clinical use as a chemotherapy drug. The present study aimed to investigate whether SET and MYND domain-containing protein 3 (SMYD3), a histone methyltransferase closely associated with tumors can affect the sensitivity of tumors to cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Xu, Man-Li, Wang, Chang, Dong, Qing-Qing, Miao, Zhi, Chen, Xiao-Ying, Wang, Nan, He, Hong-Peng, Zhang, Tong-Cun, Luo, Xue-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114722/ https://www.ncbi.nlm.nih.gov/pubmed/32269620 http://dx.doi.org/10.3892/ol.2020.11465

Ejemplares similares

Structure and Function of SET and MYND Domain-Containing Proteins
por: Spellmon, Nicholas, et al.
Publicado: (2015)

Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer
por: Alshammari, Eid, et al.
Publicado: (2022)

SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer
por: Liu, Ting-Ting, et al.
Publicado: (2016)

Structural and Functional Analysis of the DEAF-1 and BS69 MYND Domains
por: Kateb, Fatiha, et al.
Publicado: (2013)

Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma
por: Xu, Wenchao, et al.
Publicado: (2018)

SET/MYND Lysine Methyltransferases Regulate Gene Transcription and Protein Activity
por: Leinhart, Kristin, et al.
Publicado: (2011)

Is MYND Domain-Mediated Assembly of SMYD3 Complexes Involved in Calcium Dependent Signaling?
por: Zhang, Yingxue, et al.
Publicado: (2019)

Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
por: Brown, Mark A, et al.
Publicado: (2006)

Localization of a Guanylyl Cyclase to Chemosensory Cilia Requires the Novel Ciliary MYND Domain Protein DAF-25
por: Jensen, Victor L., et al.
Publicado: (2010)

Structure based functional annotation of a MYND-less lysine methyl transferase inCandida albicans
por: Dey, Joydeb, et al.
Publicado: (2022)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

Rab18 interacted with V-set and immunoglobulin domain-containing 4 (VSIG4) to involve in the apoptosis of glioma and the sensitivity to temozolomide
por: Yang, Kai, et al.
Publicado: (2021)

MiR-1298 affects cell proliferation and apoptosis in C6 cells by targeting SET domain containing 7
por: Wang, Chun-Mei, et al.
Publicado: (2017)

EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

Unmasking the mammalian SET domain-containing protein 4
por: Wang, Yuan, et al.
Publicado: (2022)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

SET Domain Containing 2 Deficiency in Myelodysplastic Syndrome
por: Li, Jiaming, et al.
Publicado: (2020)

ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells
por: Wang, Lei, et al.
Publicado: (2017)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Ehrlichia chaffeensis TRP47 enters the nucleus via a MYND-binding domain-dependent mechanism and predominantly binds enhancers of host genes associated with signal transduction, cytoskeletal organization, and immune response
por: Kibler, Clayton E., et al.
Publicado: (2018)

A Novel zf-MYND Protein, CHB-3, Mediates Guanylyl Cyclase Localization to Sensory Cilia and Controls Body Size of Caenorhabditis elegans
por: Fujiwara, Manabi, et al.
Publicado: (2010)

microRNA-10a-5p from gastric cancer cell-derived exosomes enhances viability and migration of human umbilical vein endothelial cells by targeting zinc finger MYND-type containing 11
por: Zhu, Jiaxin, et al.
Publicado: (2021)

CircRNA_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging miR-103 and promotes oxidored-nitro domain-containing protein 1 expression
por: Luo, Yanwei, et al.
Publicado: (2019)

Rho/MRTF-A-Induced Integrin Expression Regulates Angiogenesis in Differentiated Multipotent Mesenchymal Stem Cells
por: Zhang, Rui, et al.
Publicado: (2015)

Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study
por: Anderson, Kim D, et al.
Publicado: (2020)

MYNd&CO (Mindfulness, Yoga, Nutrition, development & Coaching, and Osteopathy) randomized controlled trial for a positive psychophysical experience in pregnancy and after birth: a study protocol
por: Giovannini, Niccolò, et al.
Publicado: (2021)

NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
por: Jiang, Pan, et al.
Publicado: (2016)

Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutant
por: Yu, Dan-Dan, et al.
Publicado: (2010)

ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin
por: Ma, Xiao-Yan, et al.
Publicado: (2022)

Identification of SET Domain-Containing Proteins in Gossypium raimondii and Their Response to High Temperature Stress
por: Huang, Yong, et al.
Publicado: (2016)

Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy
por: Fang, Qing-Liang, et al.
Publicado: (2020)

Increased expression of SET domain-containing proteins and decreased expression of Rad51 in different classes of renal cell carcinoma
por: Liu, Si, et al.
Publicado: (2016)

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2023)

The deduced role of a chitinase containing two nonsynergistic catalytic domains
por: Liu, Tian, et al.
Publicado: (2018)

Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
por: Peng, Shuai, et al.
Publicado: (2021)

Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations
por: Wang, Quan, et al.
Publicado: (2020)

Automatic sleep staging of single-channel EEG based on domain adversarial neural networks and domain self-attention
por: Gao, Dong-Rui, et al.
Publicado: (2023)

8-bromo-7-methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin-sensitive and resistant ovarian cancer cells
por: DING, QING, et al.
Publicado: (2015)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k1a50d0sb9cf5klhque30k9j5e